Table 5.
Prior studies of pyogenic hepatic abscess formation after embolization
| Reference | Patients (N) |
Type of HAE |
Tumor Type | Abscess N (%) |
Patients with Abscess Formation | |
|---|---|---|---|---|---|---|
| BE Anastomosis/Stent | Mortality | |||||
| N (%) | N (%) | |||||
| de Baere, 1996 | 181 | TACE | Carcinoid/NET | 3 (2) | 3 (100) | 1 (33) |
| Sakamoto, 1998 | 850 | TACE | NR | 5 (0.6) | NR | NR |
| Song, 2001 | 2,439 | TACE | HCC; GI tumors | 14 (0.6) | 4 (29) | 4 (29) |
| Kim, 2001 | 157 | TACE | NET; GI tumors | 7 (4) | 6 (86) | NR |
| Geschwind, 2002 | 258 | TACE | HCC; GI tumors; NET | 4 (2) | 4 (100) | 0 (0) |
| Huang, 2003 | 1,374 | TACE | HCC | 7 (0.3) | 0 (0) | 0 (0) |
| Ong, 2004 | 3,878* | TACE | HCC | 9 (0.2) | 0 (0) | 4 (44) |
| Current Series | 971 | Small particle | HCC; GI Tumors Carcinoid/NET | 14 (1.4) | 13 (93) | 3 (21) |
HAE = hepatic artery embolization; TACE = transarterial chemoembolization; NET = neuroendocrine tumor; NR = not reported; GI = gastrointestinal
*
number of procedures performed